Abstract
Objectives: To predict behavioral disruptions in middle childhood, we identified latent classes of prenatal substance use. Study design: As part of the Environmental influences on Child Health Outcomes Program, we harmonized prenatal substance use data and child behavior outcomes from 2195 women and their 6- to 11-year-old children across 10 cohorts in the US and used latent class–adjusted regression models to predict parent-rated child behavior. Results: Three latent classes fit the data: low use (90.5%; n = 1986), primarily using no substances; licit use (6.6%; n = 145), mainly using nicotine with a moderate likelihood of using alcohol and marijuana; and illicit use (2.9%; n = 64), predominantly using illicit substances along with a moderate likelihood of using licit substances. Children exposed to primarily licit substances in utero had greater levels of externalizing behavior than children exposed to low or no substances (P = .001, d = .64). Children exposed to illicit substances in utero showed small but significant elevations in internalizing behavior than children exposed to low or no substances (P < .001, d = .16). Conclusions: The differences in prenatal polysubstance use may increase risk for specific childhood problem behaviors; however, child outcomes appeared comparably adverse for both licit and illicit polysubstance exposure. We highlight the need for similar multicohort, large-scale studies to examine childhood outcomes based on prenatal substance use profiles.
Original language | English |
---|---|
Article number | 113468 |
Journal | Journal of Pediatrics |
Volume | 260 |
DOIs | |
Publication status | Published - Sept 2023 |
Bibliographical note
Publisher Copyright:© 2023 Elsevier Inc.
Funding
This work was supported by the Environmental influences on Child Health Outcomes (ECHO) program, Office of The Director, National Institutes of Health, under award numbers U2COD023375 (Coordinating Center), U24OD023382 (Data Analysis Center), U24OD023319 (PRO Core), 5UH3OD023320-05 (to J.A.), UG3OD023337 (to R.W.), UH3OD023268 (to Litonjua), 4UH3OD023248-03 (to D.D.), 5UH3OD023348-05 (to M.O.), 4UH3OD023328-03 (to C.D.), UH3OD023279 (to A.E.), 4UH3OD023342 (to C.N.), UH3OD023289 (to A.F., L.C.), 4UH3OD023365-03 (to I.H.), 4UH3OD023244-03 (to A.H.), 4UH3OD023275-03 (to M.K.), UH3OD023347 (to B.L.), 5TUH3OD023347 (to C.M.), UH3 OD023389 (to L.L.), UH3OD023349 (to T.O.), R01 HD 034568 and UH3OD 023286 (to E.O.), 4UH3OD023271-03 (to C.K., S.S.), UH3 OD023285 (to N.P.), and 4UH3OD023282-03 (to J.G.). The study sponsor had no role in the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no conflicts of interest.
Funders | Funder number |
---|---|
National Institutes of Health | 4UH3OD023282-03, 4UH3OD023365-03, 5UH3OD023348-05, UH3OD023349, U24OD023319, UH3OD023347, UH3OD023268, UH3OD023279, UH3OD023289, UG3OD023337, UH3OD 023286, U2COD023375, 4UH3OD023328-03, UH3 OD023285, 4UH3OD023271-03, 4UH3OD023244-03, 4UH3OD023248-03, 4UH3OD023342, 4UH3OD023275-03, U24OD023382, UH3 OD023389, R01 HD 034568, 5UH3OD023320-05 |
Office of the Director |
ASJC Scopus Subject Areas
- Pediatrics, Perinatology, and Child Health